Human papillomaviruses: genetic basis of carcinogenicity.
Persistent infection by specific oncogenic human papillomaviruses (HPVs) is established as the necessary cause of cervix cancer. DNA sequence differences between HPV genomes determine whether an HPV has the potential to cause cancer. Of the more than 100 HPV genotypes characterized at the genetic level, at least 15 are associated, to varying degrees, with cervical cancer. Classification based on nucleotide similarity places nearly all HPVs that infect the cervicovaginal area within the alpha-PV genus. Within this genus, phylogenetic trees inferred from the entire viral genome cluster all cancer-causing types together, suggesting the existence of a common ancestor for the oncogenic HPVs. However, in separate trees built from the early open reading frames (ORFs; i.e. E1, E2, E6, E7) or the late ORFs (i.e. L1, L2), the carcinogenic potential sorts with the early region of the genome, but not the late region. Thus, genetic differences within the early region specify the pathogenic potential of alpha-HPV infections. Since the HPV genomes are monophyletic and sites are highly correlated across the genome, diagnosis of oncogenic types and non-oncogenic types can be accomplished using any region across the genome. Here we review our current understanding of the evolutionary history of the oncogenic HPVs, in particular, we focus on the importance of viral genome heterogeneity and discuss the genetic basis for the oncogenic phenotype in some but not all alpha-PVs.
Burk
Robert D
RD
Department of Pediatrics, Division of Genetics, Albert Einstein Cancer Center, New York, NY 10461, USA. burk@aecom.yu.edu
Chen
Zigui
Z
Van Doorslaer
Koenraad
K
D019143:Evolution, Molecular; D005260:Female; D014644:Genetic Variation; D016679:Genome, Viral; D052162:Human papillomavirus 16 / Q000235:genetics; D006801:Humans; D008957:Models, Genetic; D027383:Papillomaviridae / Q000235:genetics*; D030361:Papillomavirus Infections / Q000150:complications / Q000235:genetics; D010641:Phenotype; D010802:Phylogeny; D002583:Uterine Cervical Neoplasms / Q000235:genetics* / Q000821:virology
Sex Transm Dis. 2007 Nov;34(11):849-55
17621246
Am J Pathol. 2000 Oct;157(4):1055-62
11021808
Cell. 1993 Nov 5;75(3):495-505
8221889
Nature. 1998 Nov 5;396(6706):84-8
9817205
Proc Natl Acad Sci U S A. 1993 May 1;90(9):3988-92
8387205
Hosp Pract (1995). 1999 Nov 15;34(12):103-11; quiz 112
10616548
J Virol. 2009 Feb;83(3):1443-55
19036820
Cell. 1990 Dec 21;63(6):1129-36
2175676
J Virol. 1993 Nov;67(11):6413-23
8411343
Int J Cancer. 2007 Jul 1;121(1):193-8
17351898
J Virol. 1982 Oct;44(1):393-400
6292500
Curr Top Microbiol Immunol. 1977;78:1-30
202434
J Virol. 1993 Nov;67(11):6424-31
8411344
Vaccine. 2006 Aug 31;24 Suppl 3:S3/1-10
16949995
Virology. 2005 Sep 15;340(1):95-104
16039686
J Virol. 1996 May;70(5):3127-36
8627792
Trends Microbiol. 2005 Nov;13(11):514-21
16181783
Eur J Biochem. 1986 Feb 3;154(3):665-72
2419131
J Infect Dis. 2005 Jun 1;191(11):1796-807
15871111
Virology. 1991 Oct;184(2):492-503
1653484
J Natl Cancer Inst Monogr. 2003;(31):20-8
12807941
Lancet. 2007 Sep 8;370(9590):890-907
17826171
J Virol. 1986 Feb;57(2):572-7
3003388
J Med Virol. 2002 Nov;68(3):417-23
12226831
Lancet. 2001 Jun 9;357(9271):1831-6
11410191
J Virol. 2005 Nov;79(21):13630-40
16227283
Proc Natl Acad Sci U S A. 1997 Oct 14;94(21):11612-6
9326658
Virology. 2005 Jun 20;337(1):76-84
15914222
N Engl J Med. 1998 Feb 12;338(7):423-8
9459645
Virology. 2004 Jun 20;324(1):17-27
15183049
J Clin Microbiol. 1995 Jul;33(7):1746-54
7665641
Vaccine. 2006 Aug 31;24 Suppl 3:S3/11-25
16949997
J Virol. 2001 May;75(9):4467-72
11287602
N Engl J Med. 2003 Feb 6;348(6):518-27
12571259
J Virol. 1989 Oct;63(10):4417-21
2476573
Science. 1989 Feb 17;243(4893):934-7
2537532
Am J Obstet Gynecol. 2003 Mar;188(3):657-63
12634637
EMBO J. 1984 May;3(5):1151-7
6329740
J Virol. 2005 Jun;79(11):7014-23
15890941
Cancer Epidemiol Biomarkers Prev. 2006 Jul;15(7):1262-7
16835321
J Mol Evol. 2002 Oct;55(4):491-9
12355268
Virology. 1997 Dec 22;239(2):296-302
9434721
J Virol. 2005 May;79(10):6565-9
15858044
CA Cancer J Clin. 2005 Mar-Apr;55(2):74-108
15761078
J Gen Virol. 2005 May;86(Pt 5):1307-1313
15831941
Oncogene. 1992 Jan;7(1):27-32
1311063
J Virol. 2005 Dec;79(24):15503-10
16306621
Int J Cancer. 2007 Aug 1;121(3):621-32
17405118
Proc Natl Acad Sci U S A. 1999 Aug 17;96(17):9557-62
10449731
Proc Natl Acad Sci U S A. 1983 Jun;80(12):3812-5
6304740
EMBO J. 1987 Jun;6(6):1741-6
3038534
Vaccine. 2006 Aug 31;24 Suppl 3:S3/42-51
16950017
Sex Transm Dis. 2007 Jul;34(7):494-502
17237737
Dis Markers. 2007;23(4):213-27
17627057
Virology. 2004 Feb 20;319(2):315-23
14980491